Preadipocytes of obese humans display gender-specific bioenergetic responses to glucose and insulin.
Adipocytes, White
/ metabolism
Adult
Carrier Proteins
/ metabolism
Cells, Cultured
Electron Transport Complex III
/ metabolism
Energy Metabolism
Female
Glucose
/ metabolism
Humans
Insulin
/ metabolism
Male
Membrane Proteins
/ metabolism
Middle Aged
Obesity
/ metabolism
Oxygen Consumption
Sex Factors
Thyroid Hormones
/ metabolism
Thyroid Hormone-Binding Proteins
Cellular metabolism
Glycolysis
Oxidative phosphorylation
Journal
Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
29
10
2018
revised:
14
11
2018
accepted:
21
11
2018
pubmed:
12
12
2018
medline:
26
11
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
Although the prevalence of obesity and its associated metabolic disorders is increasing in both sexes, the clinical phenotype differs between men and women, highlighting the need for individual treatment options. Mitochondrial dysfunction in various tissues, including white adipose tissue (WAT), has been accepted as a key factor for obesity-associated comorbidities such as diabetes. Given higher expression of mitochondria-related genes in the WAT of women, we hypothesized that gender differences in the bioenergetic profile of white (pre-) adipocytes from obese (age- and BMI-matched) donors must exist. Using Seahorse technology, we measured oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) of (pre-)adipocytes from male (n = 10) and female (n = 10) deeply-phenotyped obese donors under hypo-, normo- and hyperglycemic (0, 5 and 25 mM glucose) and insulin-stimulated conditions. Additionally, expression levels (mRNA/protein) of mitochondria-related genes (e.g. UQCRC2) and glycolytic enzymes (e.g. PKM2) were determined. Dissecting cellular OCR and ECAR into different functional modules revealed that preadipocytes from female donors show significantly higher mitochondrial to glycolytic activity (higher OCR/ECAR ratio, p = 0.036), which is supported by a higher ratio of UQCRC2 to PKM2 mRNA levels (p = 0.021). However, no major gender differences are detectable in in vitro differentiated adipocytes (e.g. OCR/ECAR, p = 0.248). Importantly, glucose and insulin suppress mitochondrial activity (i.e. ATP-linked respiration) significantly only in preadipocytes of female donors, reflecting their trends towards higher insulin sensitivity. Collectively, we show that preadipocytes, but not in vitro differentiated adipocytes, represent a model system to reveal gender differences with clinical importance for metabolic disease status. In particular preadipocytes of females maintain enhanced mitochondrial flexibility, as demonstrated by pronounced responses of ATP-linked respiration to glucose.
Sections du résumé
BACKGROUND/OBJECTIVES
Although the prevalence of obesity and its associated metabolic disorders is increasing in both sexes, the clinical phenotype differs between men and women, highlighting the need for individual treatment options. Mitochondrial dysfunction in various tissues, including white adipose tissue (WAT), has been accepted as a key factor for obesity-associated comorbidities such as diabetes. Given higher expression of mitochondria-related genes in the WAT of women, we hypothesized that gender differences in the bioenergetic profile of white (pre-) adipocytes from obese (age- and BMI-matched) donors must exist.
SUBJECTS/METHODS
Using Seahorse technology, we measured oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) of (pre-)adipocytes from male (n = 10) and female (n = 10) deeply-phenotyped obese donors under hypo-, normo- and hyperglycemic (0, 5 and 25 mM glucose) and insulin-stimulated conditions. Additionally, expression levels (mRNA/protein) of mitochondria-related genes (e.g. UQCRC2) and glycolytic enzymes (e.g. PKM2) were determined.
RESULTS
Dissecting cellular OCR and ECAR into different functional modules revealed that preadipocytes from female donors show significantly higher mitochondrial to glycolytic activity (higher OCR/ECAR ratio, p = 0.036), which is supported by a higher ratio of UQCRC2 to PKM2 mRNA levels (p = 0.021). However, no major gender differences are detectable in in vitro differentiated adipocytes (e.g. OCR/ECAR, p = 0.248). Importantly, glucose and insulin suppress mitochondrial activity (i.e. ATP-linked respiration) significantly only in preadipocytes of female donors, reflecting their trends towards higher insulin sensitivity.
CONCLUSIONS
Collectively, we show that preadipocytes, but not in vitro differentiated adipocytes, represent a model system to reveal gender differences with clinical importance for metabolic disease status. In particular preadipocytes of females maintain enhanced mitochondrial flexibility, as demonstrated by pronounced responses of ATP-linked respiration to glucose.
Identifiants
pubmed: 30528280
pii: S2212-8778(18)31046-9
doi: 10.1016/j.molmet.2018.11.006
pmc: PMC6358537
pii:
doi:
Substances chimiques
Carrier Proteins
0
Insulin
0
Membrane Proteins
0
Thyroid Hormones
0
Electron Transport Complex III
EC 7.1.1.8
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
28-37Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier GmbH.. All rights reserved.
Références
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E380-7
pubmed: 26081284
J Appl Physiol (1985). 2014 Nov 1;117(9):1008-19
pubmed: 25190743
Biochim Biophys Acta. 2014 Feb;1837(2):270-6
pubmed: 24212054
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7996-8001
pubmed: 12808136
Am J Clin Nutr. 2008 Jan;87(1):56-63
pubmed: 18175737
Nat Commun. 2017 Mar 27;8:14892
pubmed: 28345670
Sci Rep. 2017 Jun 22;7(1):4031
pubmed: 28642596
Cytometry A. 2003 Feb;51(2):127-8; author reply 129
pubmed: 12541287
FEBS Lett. 1979 May 15;101(2):411-4
pubmed: 446765
PLoS Med. 2007 May;4(5):e154
pubmed: 17472434
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
J Neurol Sci. 1984 Sep;65(3):323-31
pubmed: 6238135
Diabetes Metab J. 2014 Feb;38(1):74-80
pubmed: 24627831
Respir Physiol Neurobiol. 2005 Apr 15;146(2-3):107-16
pubmed: 15766899
Mol Metab. 2017 Oct;6(10):1226-1239
pubmed: 29031722
Mol Metab. 2015 May 01;4(7):519-27
pubmed: 26137439
J Biol Chem. 2009 Jan 23;284(4):2383-96
pubmed: 19036730
J Biol Chem. 2015 Oct 23;290(43):25834-46
pubmed: 26342081
J Appl Physiol (1985). 1997 Jul;83(1):166-71
pubmed: 9216960
FASEB J. 2014 Feb;28(2):761-70
pubmed: 24200885
Int J Obes Relat Metab Disord. 2002 Jan;26(1):6-16
pubmed: 11791141
J Appl Physiol (1985). 2005 Jan;98(1):160-7
pubmed: 15333616
J Clin Invest. 2004 Nov;114(9):1281-9
pubmed: 15520860
Int J Obes Relat Metab Disord. 1998 May;22(5):448-53
pubmed: 9622342
J Cell Biol. 2007 Apr 9;177(1):73-86
pubmed: 17420291
Nat Rev Mol Cell Biol. 2008 May;9(5):367-77
pubmed: 18401346
J Intern Med. 2011 Feb;269(2):189-99
pubmed: 21205021
J Clin Endocrinol Metab. 2013 Feb;98(2):E370-8
pubmed: 23264395
J Diabetes Metab Disord. 2014 Feb 20;13(1):35
pubmed: 24555754
J Clin Invest. 1995 May;95(5):2111-9
pubmed: 7738178
Br J Nutr. 2010 Oct;104(8):1139-47
pubmed: 20540820
Med Sci Sports Exerc. 2008 Apr;40(4):648-54
pubmed: 18317381
J Clin Endocrinol Metab. 2014 Feb;99(2):E209-16
pubmed: 24276464
Int J Obes (Lond). 2017 Oct;41(10):1564-1569
pubmed: 28630459
Am J Physiol. 1984 Mar;246(3 Pt 1):E211-5
pubmed: 6367483
Diabetes. 2010 Oct;59(10):2474-83
pubmed: 20682684
Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15
pubmed: 11244452
Diabetes. 2009 Apr;58(4):803-12
pubmed: 19136652
FASEB J. 2009 Jun;23(6):1869-79
pubmed: 19190082
Am J Physiol. 1993 Sep;265(3 Pt 1):E374-9
pubmed: 8214046
FASEB J. 1995 Feb;9(2):273-8
pubmed: 7781930
Diabetes Res Clin Pract. 2011 Oct;94(1):146-55
pubmed: 21824674
BMC Obes. 2015 Oct 06;2:40
pubmed: 26448868
Front Endocrinol (Lausanne). 2014 Nov 13;5:195
pubmed: 25431568
PLoS One. 2014 Apr 02;9(4):e93148
pubmed: 24695116
Diabetes. 2007 Dec;56(12):2973-81
pubmed: 17827403
Diabetes. 2015 Sep;64(9):3135-45
pubmed: 25972572
Gend Med. 2009;6 Suppl 1:60-75
pubmed: 19318219
Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1472-80
pubmed: 9261282
J Clin Endocrinol Metab. 2002 Feb;87(2):764-71
pubmed: 11836318
Am J Clin Nutr. 2009 May;89(5):1307-14
pubmed: 19297456
Horm Metab Res. 2008 Dec;40(12):854-60
pubmed: 18819055
Circ Res. 2008 Feb 29;102(4):401-14
pubmed: 18309108